RXL250117P53000
- 0.00
- 0.000.00%
Proshares Trust Pshs Ult Hlthcre Newsroom
Merck's male HPV vaccine has been approved domestically for the first time. Industry insiders believe this will promote the future approval of domestic products under development.
① Gardasil has become the first and currently the only approved HPV vaccine for men in China. ② Industry experts believe that the approval of the new indication is a new exploration in terms of pharmacological principles and other aspects. ③ Currently, companies such as Kang Li Wei Shi and Beijing Wantai Biological Pharmacy Enterprise have made arrangements in this field.
Anteris Technologies Positioned To Capture 4%-5% Of US Transcatheter Valve Replacement Market By 2030: Analyst
These Stocks Are Expected to See at Least 25% Revenue Growth in 2025 – Wolfe
Bullish Outlook On Instil Bio's Investigational Cancer Drug: Jefferies Sees Over 300% Stock Upside
Unpacking the Latest Options Trading Trends in Merck & Co
Merck Buys WuXi Vaccines' Irish Manufacturing Facility For Over $500 Million
FDA Issues Draft Guidance on Developing Weight Loss Drugs
Citi Says 'Buy' These Stocks in '25; SA Quant Ratings Says Maybe Not
Merck & Compnay and OPKO Health Shares Are Trading Higher After the Companies Announced a License and Collaboration Agreement to Develop an Epstein-Barr Virus Vaccine.
J&J Rybrevant/Lazcluze Combo Bests AstraZeneca's Tagrisso in NSCLC
Eli Lilly's Options: A Look at What the Big Money Is Thinking
Johnson & Johnson Announces RYBREVANT Plus LAZCLUZE Show Statistically Significant And Clinically Meaningful Improvement In Overall Survival Versus Osimertinib; Median Overall Survival Improvement Expected To Exceed One Year; First And Only Regimen...
AbbVie Announced Q4 2024 Earnings To Include $1.6B Acquired IPR&D Costs, Impacting EPS By $0.88; Final Results Pending; Q4 Adj EPS $2.06-$2.10; FY24 Adj EPS Guidance $10.02-$10.06
FDA Issues First Draft Guidance on Use of AI in Drug, Medical Device Development
Merck to Buy Vaccine Plant From WuXi Biologics: Report
Citi's Recommended List of Large-cap Stocks: GOOGL, STZ, DAL, and More
Healthcare Sector's 2024 Gainers and Losers: Intuitive Surgical, Boston Scientific Tops Chart
WUXI BIO has once again divested overseas Assets! Merck takes over WUXI BIO's Ireland vaccine factory for 0.5 billion USD | Quick read announcement.
① WUXI BIO announced today that it will sell the Ireland vaccine factory to Merck for 0.5 billion USD; ② this vaccine factory was originally built to undertake Merck's vaccine contract manufacturing business; ③ not long ago, WUXI APPTEC also divested its WuXi ATU business in the USA and United Kingdom.
UnitedHealth Group Analyst Ratings
The "dark horses" in the stock market are coming in 2025: Four dark horse stocks that strategists are bullish on.
The stock market in 2025 is full of uncertainty, but for those investors who dare to select stocks precisely, there are still huge opportunities hidden.